0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)
ABSTRACT: Free Communications: Ovarian Cancer Saturday, October 14, 2006
0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)
PDF